12 completed, 3 terminated, 2 unknown, 1 withdrawn. 9 Phase 2, 4 Phase 4, 3 Phase 1, 3 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Terminated 3 |
| Phase 4 | 4 | Completed 3, Unknown 1 |
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Not applicable | 1 | Completed 1 |
Follow Placebo - Cap: new trials by email Literature Review of Placebo - Cap trials Research Report on Placebo - Cap
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabergoline for the Treatment of Chronic Pain Due to Endometriosis Cabergoline 0.5 MG, Placebo - Cap - Endometriosis | Phase 2 | Completed | Boston Children's Hospital | 129 | 2019-12-02 | 2026-01-28 |
| ENAC Blockade and Arterial Stiffness Placebo - Cap, Amiloride Pill - Overweight and Obesity, Insulin Resistance | Phase 2 / Phase 3 | Completed | University of Missouri-Columbia | 137 | 2019-07-15 | 2025-12-30 |
| The Effect of Ramelteon on Delirium and Sleep in Patients Admitted to the ICU Ramelteon, Placebo - Cap - Delirium | Phase 4 | Completed | Rhode Island Hospital | 112 | 2019-05-09 | 2024-04-10 |
| A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. Dabigatran, Placebo - Cap - Mild Cognitive Impairment, Mild Alzheimer's Disease | Phase 1 | Withdrawn | University of Rhode Island | 2019-05-01 | 2025-04-17 | |
| Modulating the Vaginal Microbiome After Implantation Failure Vivag Plus, Placebo - Cap - Implantation Failure, Infertility, Female | Phase 4 | Completed | Zealand University Hospital | 74 | 2019-03-01 | 2021-03-23 |
| Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension Dapagliflozin, Placebo - Cap - Hypertension | Phase 4 | Unknown | University of Guadalajara | 20 | 2019-02-14 | 2020-12-28 |
| Evening Primrose Oil Efficacy in Second Trimester Abortion Evening primrose oil(EPO), Placebo - Cap - Missed Abortion | Phase 3 | Unknown | Ain Shams University | 100 | 2018-11-01 | 2018-10-09 |
| Fexofenadine Use in Gastroesophageal Reflux Symptoms Fexofenadine, Placebo - Cap - Gastroesophageal Reflux | Phase 2 | Terminated | Stanford University | 11 | 2018-02-07 | 2021-02-17 |
| INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers Mifepristone, Placebo - Cap - Alcohol Use Disorder | Phase 1 / Phase 2 | Completed | Johns Hopkins University | 65 | 2017-09-26 | 2025-05-30 |
| OPTIMA-TBI Pilot Study Omega-3 Polyunsaturated Fatty Acids (Fish Oil 1000 mg (contains 500 mg DHA & 100 mg EPA)) or placebo capsules., Placebo - Cap - Mild Traumatic Brain Injury | Phase 2 | Terminated | University of Michigan | 44 | 2017-09-12 | 2023-05-23 |
| Pharmacological Modulation of Belief Salience Placebo - Cap, L-dopa, Haloperidol - Haloperidol, Placebo | Phase 1 | Completed | King's College London | 30 | 2017-06-01 | 2019-10-10 |
| A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia SEP-363856, Placebo - Cap - Schizophrenia | Phase 2 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 245 | 2016-12-05 | 2024-07-05 |
| Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis Lactobacillus rhamnosus, Placebo - Cap - Hemodialysis Complication | Not applicable | Completed | nooshin dalili | 42 | 2016-09-01 | 2018-05-17 |
| Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension Dapagliflozin, Placebo - Cap - PreDiabetes, Prehypertension | Phase 4 | Completed | University of Guadalajara | 30 | 2016-03-30 | 2020-11-09 |
| Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer escitalopram, Moclobemide, Placebo - Cap - Addiction | Phase 2 | Terminated | China Medical University Hospital | 90 | 2016-01-14 | 2019-07-24 |
| NMDA Modulation in Major Depressive Disorder in Late- Life NMDA, Sertraline, Placebo - Cap - Depressive Disorder, Major | Phase 2 | Completed | Chang Gung Memorial Hospital | 136 | 2016-01-01 | 2020-12-01 |
| Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function Anastrozole 1mg, Clomiphene Citrate 25mg, Placebo - Cap - Hypogonadism, Male | Phase 2 | Completed | Albany Medical College | 24 | 2015-04-02 | 2019-11-18 |
| Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis Broncho-Vaxom, Placebo - Cap - Atopic Dermatitis | Phase 3 | Completed | Vifor Pharma | 179 | 2003-07-01 | 2017-02-09 |
Abortion, Missed (1) · Alcoholism (1) · Behavior, Addictive (1) · Brain Concussion (1) · Cognitive Dysfunction (1) · Delirium (1) · Depressive Disorder, Major (1) · Dermatitis, Atopic (1) · Endometriosis (1) · Eunuchism (1) · Gastroesophageal Reflux (1) · Hypertension (1) · Infertility, Female (1) · Insulin Resistance (1) · Obesity (1)
University of Guadalajara (2) · Ain Shams University (1) · Albany Medical College (1) · Boston Children's Hospital (1) · Chang Gung Memorial Hospital (1) · China Medical University Hospital (1) · Johns Hopkins University (1) · King's College London (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Rhode Island Hospital (1) · Stanford University (1) · University of Michigan (1) · University of Missouri-Columbia (1) · University of Rhode Island (1) · Vifor Pharma (1)
United States (7) · Mexico (2) · Denmark (1) · Egypt (1) · Hungary (1) · Romania (1) · Russia (1) · Taiwan (1) · Ukraine (1) · United Kingdom (1)
Camila Manrique Acevedo, MD (1) · Frederick Korley, M.D., Ph.D. (1) · John Stoukides, MD (1) · Ko Ying-Chin, PHD (1) · Mary E McCaul, PhD (1) · Mitchell M Levy, MD, MCCM, FCCP (1) · Paula Grammas, PhD (1) · Robert C Welliver, MD (1) · Yves De Prost, MD (1)
PMID 12505794, PMID 16929307, PMID 20057930, PMID 32294346, PMID 35023557, PMID 36369028, PMID 36531460
2016 (1), U01AA020890 (1)